Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
John Elmer Cabang Quilisadio, Evelyn Osio Salido & Ester Gonzales Penserga. (2021) Achievement of the target serum urate level among patients with gout treated with allopurinol or febuxostat in an arthritis clinic in the Philippines. Modern Rheumatology 31:3, pages 755-761.
Read now
Read now
Paul P. Doghramji, Steve Fermer, Robert Wood, Robert Morlock & Scott Baumgartner. (2016) Management of gout in the real world: current practice versus guideline recommendations. Postgraduate Medicine 128:1, pages 106-114.
Read now
Read now
Articles from other publishers (23)
Kah Mun Cheong, Melonie Kannamma Sriranganathan & Elena Meishan Lee. (2023) Impact of pharmacist-led collaborative gout clinic on timely achievement of serum uric acid goals. Proceedings of Singapore Healthcare 32, pages 201010582311520.
Crossref
Crossref
Zheng Cong Lee, Anindita Santosa, Andrew Yu Keat Khor & Melonie K Sriranganathan. (2023) The Singapore Experience With Uncontrolled Gout: Unmet Needs in the Management of Patients. Cureus.
Crossref
Crossref
Mark D Russell, Benjamin D Clarke, Edward Roddy & James B Galloway. (2022) Improving outcomes for patients hospitalized with gout: a systematic review. Rheumatology 61:1, pages 90-102.
Crossref
Crossref
Meykkumar Meyappan, Wei Siong Aaron Loh, Li Yen Tan, Sheng Feng Ian Tan, Pey Ying Ho, Yih Jia Poh & Ngiap Chuan Tan. (2021) Development of a novel gout treatment patient decision aid by patient and physician: A qualitative research study. Health Expectations 24:2, pages 431-443.
Crossref
Crossref
Puja Khanna, Veronica Berrocal, Larry An & Dinesh Khanna. (2020) Development and Pilot Testing of MyGoutCare. JCR: Journal of Clinical Rheumatology 26:8, pages 320-326.
Crossref
Crossref
Kee Fong Phang, Amelia Santosa, Bernadette P. L. Low, Pamela S. H. Tan, Zhi Wei Khong, Anita Y. N. Lim, Gim Gee Teng & Sen Hee Tay. (2020) A nurse‐led, rheumatologist‐assisted telemedicine intervention for dose escalation of urate‐lowering therapy in gout. International Journal of Rheumatic Diseases 23:9, pages 1136-1144.
Crossref
Crossref
Iqbal Gill, Nicola Dalbeth, Malakai 'Ofanoa & Felicity Goodyear-Smith. (2020) Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review. BJGP Open 4:3, pages bjgpopen20X101051.
Crossref
Crossref
Cheryl K. T. Chua, Peter P. Cheung, Amelia Santosa, Anita Y. N. Lim & Gim Gee Teng. (2019) Burden and management of gout in a multi-ethnic Asian cohort. Rheumatology International 40:7, pages 1029-1035.
Crossref
Crossref
Gim Gee Teng, Wei-Chuen Tan-Koi, Di Dong & Cynthia Sung. (2020) Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease?. Pharmacogenomics 21:4, pages 279-291.
Crossref
Crossref
Irvin J. Huang, Jean W. Liew, Meredith B. Morcos, Silu Zuo, Carol Crawford & Alison M. Bays. (2019) Pharmacist-managed titration of urate-lowering therapy to streamline gout management. Rheumatology International 39:9, pages 1637-1641.
Crossref
Crossref
Weixian Lee, Gim Gee Teng, Joon Chong Kok, Amelia Santosa, Anita Y. N. Lim & Hwee‐Lin Wee. (2019) Validity and reliability of the Gout Impact Scale in a multi‐ethnic Asian population. International Journal of Rheumatic Diseases.
Crossref
Crossref
Matthew J. Coleshill, Eindra Aung, Amy D. Nguyen, Sophie L. Stocker, Melissa T. Baysari, Bishoy Kamel, Marcel Schulz, Andrew J. McLachlan & Richard O. Day. (2019) Improving adherence to urate‐lowering therapy in people living with gout. International Journal of Rheumatic Diseases 22:4, pages 542-544.
Crossref
Crossref
Lydia Wenxin Lin, Gim Gee Teng, Anita Yee Nah Lim, Joanne Su‐Yin Yoong, Niklas Zethraeus & Hwee‐Lin Wee. (2018) Cost‐effectiveness of an adherence‐enhancing intervention for gout based on real‐world data. International Journal of Rheumatic Diseases 22:4, pages 545-554.
Crossref
Crossref
Augustin Latourte, Thomas Bardin, Pierre Clerson, Hang‐Korng Ea, René‐Marc Flipo & Pascal Richette. (2018) Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate‐Lowering Therapy. Arthritis Care & Research 70:6, pages 918-924.
Crossref
Crossref
Ari Polachek, Dafna D. Gladman, Jiandong Su & Murray B. Urowitz. (2017) Defining Low Disease Activity in Systemic Lupus Erythematosus. Arthritis Care & Research 69:7, pages 997-1003.
Crossref
Crossref
U Kiltz, J Smolen, T Bardin, A Cohen Solal, N Dalbeth, M Doherty, B Engel, C Flader, J Kay, M Matsuoka, F Perez-Ruiz, G da Rocha Castelar-Pinheiro, K Saag, A So, J Vazquez Mellado, M Weisman, T H Westhoff, H Yamanaka & J Braun. (2017) Treat-to-target (T2T) recommendations for gout. Annals of the Rheumatic Diseases 76:4, pages 632-638.
Crossref
Crossref
FL Chia. (2016) Poorly controlled gout: who is doing poorly?. Singapore Medical Journal 57:8, pages 412-414.
Crossref
Crossref
Marloes van Onna, Elke Hinsenveld, Hein de Vries & Annelies Boonen. (2014) Health literacy in patients dealing with gout: a qualitative study. Clinical Rheumatology 34:9, pages 1599-1603.
Crossref
Crossref
Eric Wise & Puja P. Khanna. (2015) The impact of gout guidelines. Current Opinion in Rheumatology 27:3, pages 225-230.
Crossref
Crossref
Fernando Perez-Ruiz & Ana Maria Herrero-Beites. (2014) Gout treatment—more tablets might be needed. Nature Reviews Rheumatology 10:3, pages 193-193.
Crossref
Crossref
Bonifacio Álvarez-Lario & José L. Alonso-Valdivielso. (2014) Gout treatment: when a tablet is not enough. Nature Reviews Rheumatology 10:3, pages 193-193.
Crossref
Crossref
Xavier Tena. (2014) El factor humano en la gota. Seminarios de la Fundación Española de Reumatología 15:1, pages 3-5.
Crossref
Crossref
Hyo Jin ChoiSeung Kak ShinMi Ryung SeoHee Jung RyuHan Joo Baek. (2013) Duration of Prophylactic Therapy Affects the Frequency of Gout Flare. Journal of Rheumatic Diseases 20:1, pages 17.
Crossref
Crossref